Dose-dependent influence of barbiturates but not of propofol on human leukocyte phagocytosis of viable Staphylococcus aureus

Critical Care Medicine

Volumn 34, Issue 2, 2006, Pages 478-483

  Ploppa, Annette ^a   Kiefer, Ralph Thomas ^a   Nohé, Boris ^a   Haeberle, Helene A ^a   Dieterich, Hans Jürgen ^a   Unertl, Klaus E ^a   Krueger, Wolfgang A ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BARBITURIC ACID DERIVATIVE; BREVIMYTHAL 660; METHOHEXITAL; MONOCLONAL ANTIBODY; PHENOL DERIVATIVE; PROPOFOL; THIOPENTAL;

ADULT; ARTICLE; BLOOD SAMPLING; CALCULATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; FLOW CYTOMETRY; FLUORESCENCE ANALYSIS; GRANULOCYTE FUNCTION; HUMAN; IC 50; INCUBATION TIME; LEUKOCYTE FUNCTION; LEUKOCYTE MIGRATION; NORMAL HUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; STAINING; STAPHYLOCOCCUS AUREUS; STATISTICAL SIGNIFICANCE;

EID: 31344434755     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000199067.71968.6E     Document Type: Article

References (28)

1. Stover JF, Stocker R: Barbiturate coma may promote reversible bone marrow suppression in patients with severe isolated traumatic brain injury. Eur J Clin Pharmacol 1998; 54:529-534
2. Eberhardt KEW, Thimm BM, Spring A, et al: Dose-dependent rate of nosocomial pulmonary infection in mechanically ventilated patients with brain oedema receiving barbiturates: A prospective case study. Infection 1992; 20:12-21
3. Krueger WA, Lenhart F-P, Neeser G, et al: Influence of combined intravenous and topical antibiotic prophylaxis on the incidence of infections, organ dysfunctions, and mortality in critically ill surgical patients. Am J Respir Crit Care Med 2002; 166:1029-1037
4. Nadal P, Nicolas JM, Font C, et al: Pneumonia in ventilated head trauma patients: The role of thiopental therapy. Eur J Emerg Med 1995; 2:14-16
5. Galley HF, DiMatteo MA, Webster NR: Immunomodulation by anesthetic, sedative and analgesic agents: Does it matter? Intensive Care Med 2000; 26:267-274
6. Davidson JAH, Boom SJ, Pearsall FJ, et al: Comparison of the effects of four i.v. anaesthetic agents on polymorphonuclear leukocyte function. Br J Anaesth 1995; 74:315-331
7. Heller A, Heller S, Blecken S, et al: Effect of intravenous anaesthetics on bacterial elimination in human blood in vitro. Acta Anaesthesiol Scand 1998; 42:518-526
8. Rello J, Quintana E, Ausina V, et al: Risk factors for Staphylococcus aureus nosocomial pneumonia in critically ill patients. Am Rev Respir Dis 1990, 142:1320-1324
9. Bronchard R, Albaladejo P, Brezac G, et al: Early onset pneumonia. Anesthesiology 2004; 100:234-239
10. Campbell W, Hendrix E, Schwalbe R, et al: Head-injured patients who are nasal carriers of Staphylococcus aureus are at high risk for Staphylococcus aureus pneumonia. Crit Care Med 1999; 27:798-801
11. Kiefer RT, Ploppa A, Krueger WA, et al: Local anesthetics impair human granulocyte phagocytosis activity, oxidative burst, and CD11b expression in response to Staphylococcus aureus. Anesthesiology 2003; 98:842-848
12. Russo H, Dubboin MP, Bressole F, et al: Time-dependent pharmacokinetics of high dose thiopental infusion in intensive care patients. Pharmaceutical Research 1997; 14:1583-1588
13. Russo H, Urien S, Duboin MP, et al: Pharmacokinetics of high-dosage thiopental sodium in patients with cerebral injuries. Clin Drug Invest 1997; 13:255-269
14. Turcant A, Delhumeau A, Premel-Cabic A, et al: Thiopental pharmacokinetics under conditions of long-term infusion. Anesthesiology 1985; 63:50-54
15. Schickendanz J, Funk W, Ittner KP, et al: Elimination of methohexitone after long term, high dose infusion in patients with critically elevated intracranial pressure. Crit Care Med 1999; 27:1570-1576
16. Barr J, Egan TD, Sandoval NF, et al: Propofol dosing regimens for ICU sedation based upon an integrated pharmacokinetic-pharmacodynamic model. Anesthesiology 2001; 95:324-333
17. Steiner LA, Johnston AJ, Chatfield DA, et al: The effects of large dose propofol on cerebrovascular pressure autoregulation in head-injured patients. Anesth Analg 2003; 97: 572-576
18. Krumholz W, Endrass J, Hempelmann G: Inhibition of phagocytosis and killing of bacteria by anaesthetic agents in vitro. Br J Anaesth 1995; 75:66-70
19. Kress HG, Eberlein T, Hörber B, et al: Suppression of neutrophil migration and chemiluminescence is due to the sulphur atom in the thiobarbiturate molecule. Acta Anaesthesiol Scand 1989; 33:122-128
20. Mikawa K, Maekawa N, Hoshina H, et al: Inhibitory effect of barbiturates and local anaesthetics on protein kinase C activation. J Internatl Med Res 1990; 18:153-160
21. Loop T, Liu Z, Humar M, et al: Thiopental inhibits the activation of nuclear factor kB. Anesthesiology 2002; 96:1202-1213
22. Haeberle HA, Kiefer RT: Thiopental and nuclear factor kB: Some questions. Anesthesiology 2003; 98:1020
23. Rossi L, Wessiepe M, Buhre W, et al: Effects of propofol on adhesion of activated platelets to leukocytes in human whole blood. Intensive Care Med 2003; 29:1157-1163
24. Heine J, Jaeger K, Weingaertner N, et al: Effects of different preparations of propofol, diazepam, and etomidate on human neutrophils in vitro. Acta Anaesthesiol Scand 2001; 45:213-220
25. Galley HF, Dubbels AM, Webster NR: The effect of midazolam and propofol on interleukin-8 from human polymorphonuclear leukocytes. Anesth Analg 1998; 86:1289-1293
26. Krumholz W, Endrass J, Hempelmann G: Propofol inhibits phagocytosis and killing of Staphylococcus aureus and Escherichia coli by polymorphonuclear leucocytes in vitro. Can J Anaesth 1994; 41:446-449
27. Kelbel I, Koch T, Weber A, et al: Alterations of bacterial clearance induced by propofol. Acta Anaesthesiol Scand 1999; 443:71-76
28. Skoutelis A, Lianou P, Papageorgiou E, et al: Effects of propofol and thiopentone on polymorphonuclear lukocyte functions in vitro. Acta Anaesthesiol Scand 1994; 38:858-862